Andrew Booth's most recent trade in AbCellera Biologics Inc was a trade of 1,352,054 Share option (right to buy) done . Disclosure was reported to the exchange on Jan. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 1,352,054 | 7,942,951 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 770,416 | 6,590,897 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 6.85 per share. | 26 May 2023 | 14,500 | 153,000 | - | 6.9 | 99,325 | Common Shares |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2022 | 50,000 | 5,820,481 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2022 | 50,000 | 138,500 | - | 0 | Common shares | |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.19 per share. | 20 Dec 2022 | 50,000 | 188,500 | - | 0.2 | 9,500 | Common Shares |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 485,661 | 5,870,481 | - | - | Share Options (right to buy) | |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.79 per share. | 12 May 2022 | 85,000 | 138,500 | - | 5.8 | 492,150 | Common Shares |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 406,020 | 5,884,820 | - | - | Share Option (right to buy) | |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 14.74 per share. | 11 Nov 2021 | 53,500 | 53,500 | - | 14.7 | 788,590 | Common Shares |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 14.61 per share. | 11 Nov 2021 | 14,000 | 130,959 | - | 14.6 | 204,540 | Common Shares |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.50 per share. | 09 Jun 2021 | 1,200,000 | 0 | - | 25.5 | 30,600,000 | Common Shares |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.32 per share. | 07 Jun 2021 | 600,000 | 1,200,000 | - | 0.3 | 192,000 | Common Shares |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 600,000 | 4,950,000 | - | - | Share Option (right to buy) | |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 600,000 | 300,000 | - | - | Share Option (right to buy) | |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.19 per share. | 07 Jun 2021 | 600,000 | 600,000 | - | 0.2 | 114,000 | Common Shares |